Sign in
4

Changes in Ownership

Milestone Pharmaceuticals Inc. Filed Acc 0001209191-22-054328

Director bought 15,000 shares at $4.93 ($73,950)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Wills Robert James Director 2022-10-19 Purchase +15,000 $4.93 $73,950 15,000 D
Open-market purchases · 15,000 sh · avg $4.93 · $73,950
Loading xslF345X03/doc4.xml…